Preclinical activity of a novel multi-axis inhibitor in aggressive and indolent B-cell malignancies

Audrey L. Smith, Dhananjaya Pal, Rolando Martinez-Rico, Alexandria P. Eiken, Donald L Durden, Tatiana G. Kutateladze, Dalia El-Gamal

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
JournalLeukemia and Lymphoma
StateAccepted/In press - 2023


  • chronic lymphocytic leukemia
  • ibrutinib-resistance
  • Mantle cell lymphoma
  • novel BTK/PI3K/BRD4 inhibitor
  • targeted multi-axis treatment

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this